{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+Alone&page=4", "query": { "intervention": "Standard of Care Alone", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 2874, "total_pages": 288, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+Alone&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+Alone&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-12T15:43:04.508Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03207646", "title": "Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Acute Coronary Syndrome" ], "interventions": [ { "name": "BrightHeart®", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 63, "start_date": "2017-07-19", "completion_date": "2018-08-17", "has_results": false, "last_update_posted_date": "2018-09-10", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207646" }, { "nct_id": "NCT04919161", "title": "Explorations of the Benefits of the ZeroG TRiP System to Improve Balance in Patients Following Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stroke", "Balance; Distorted" ], "interventions": [ { "name": "Body weight support system control group", "type": "DEVICE" }, { "name": "Body weight support system with balance perturbations", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Gaylord Hospital, Inc", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2019-10-03", "completion_date": "2020-08-28", "has_results": true, "last_update_posted_date": "2021-08-17", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Wallingford, Connecticut", "locations": [ { "city": "Wallingford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04919161" }, { "nct_id": "NCT03467373", "title": "A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "B-Cell Lymphoma", "Non-Hodgkin Lymphoma" ], "interventions": [ { "name": "Glofitamab", "type": "DRUG" }, { "name": "Obinutuzumab (G)", "type": "DRUG" }, { "name": "Rituximab (R)", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Polatuzumab vedotin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 111, "start_date": "2018-03-13", "completion_date": "2024-12-02", "has_results": false, "last_update_posted_date": "2025-01-17", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Charlotte, North Carolina • Philadelphia, Pennsylvania", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03467373" }, { "nct_id": "NCT07799883", "title": "Reducing Chronic Pain Following Cesarean Delivery", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain", "Cesarean Section Complications", "Postpartum" ], "interventions": [ { "name": "Empowered Relief", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2026-10-05", "completion_date": "2027-03-14", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07799883" }, { "nct_id": "NCT06560502", "title": "Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Foot Ulcer", "Venous Leg Ulcer", "Ulcer Foot", "Leg Ulcer" ], "interventions": [ { "name": "Standard of Care-DFU", "type": "OTHER" }, { "name": "AmnioCore - DFU", "type": "OTHER" }, { "name": "Amnio Quad-Core - DFU", "type": "OTHER" }, { "name": "Standard of Care-VLU", "type": "OTHER" }, { "name": "Amnio Tri-Core - VLU", "type": "OTHER" }, { "name": "Amniocore Pro +", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Stability Biologics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 324, "start_date": "2024-08-01", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2025-01-20", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Circleville, Ohio", "locations": [ { "city": "Circleville", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06560502" }, { "nct_id": "NCT03699319", "title": "CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "CPI 613", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "5-flurouracil", "type": "DRUG" }, { "name": "Folinic acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David Bajor, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 49, "start_date": "2018-12-07", "completion_date": "2024-09-23", "has_results": false, "last_update_posted_date": "2025-01-23", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03699319" }, { "nct_id": "NCT00266773", "title": "A Telephone Feedback System for Prevention of Chronic Pain Relapse", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain and Relapse Prevention" ], "interventions": [ { "name": "Chronic pain therapeutic interactive voice response (TIVR) system", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Vermont", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 158, "start_date": "2005-11", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2013-02-18", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Burlington, Vermont", "locations": [ { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT00266773" }, { "nct_id": "NCT07805083", "title": "Community Enhanced Virtual Informed Consent", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hematopoietic and Lymphatic System Neoplasm", "Malignant Solid Neoplasm" ], "interventions": [ { "name": "Educational Cancer Intervention", "type": "BEHAVIORAL" }, { "name": "ICF Text Version 1", "type": "OTHER" }, { "name": "ICF Text Version 2", "type": "OTHER" }, { "name": "ICF Video Version 1", "type": "OTHER" }, { "name": "ICF Video Version 2", "type": "OTHER" }, { "name": "ICF Video Version 3", "type": "OTHER" }, { "name": "ICF Video Version 4", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2026-07-21", "completion_date": "2029-07-20", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07805083" }, { "nct_id": "NCT07226583", "title": "Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes Mellitus", "Exercise Physiology" ], "interventions": [ { "name": "Standard-of-Care Guidance (SoC)", "type": "BEHAVIORAL" }, { "name": "Usual Care (UC)", "type": "BEHAVIORAL" }, { "name": "netIOB & Exercise Toolkit (NEXT)", "type": "DEVICE" }, { "name": "Continuous Glucose Monitoring", "type": "DEVICE" }, { "name": "Continuous Ketone Monitoring", "type": "DEVICE" } ], "intervention_types": [ "BEHAVIORAL", "DEVICE" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 20, "start_date": "2026-10", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07226583" }, { "nct_id": "NCT01350245", "title": "Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Biphenotypic Leukemia", "Acute Lymphocytic Leukemia", "Chronic Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Plasma Cell Neoplasms", "Lymphoma", "Hodgkin's Disease", "Aplastic Anemia" ], "interventions": [ { "name": "Total Body Irradiation (TBI)", "type": "RADIATION" }, { "name": "Donor Lymphocyte Infusion (DLI)", "type": "BIOLOGICAL" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Mycophenolate Mofetil (MMF)", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Hematopoietic stem cell transplantation (HSCT)", "type": "DEVICE" } ], "intervention_types": [ "RADIATION", "BIOLOGICAL", "DRUG", "DEVICE" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2010-07", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2025-05-16", "last_synced_at": "2026-10-12T15:43:04.508Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01350245" } ] }